← FDA DRUG APPROVALS

FDA ANDA · ANDA074098

DOBUTAMINE HYDROCHLORIDE

Sponsor: TELIGENT

APPLICATION
ANDA074098
TYPE
ANDA
ORIGINAL APPROVAL
1995-02-21
LATEST ACTION
2002-10-22
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

DOBUTAMINE HYDROCHLORIDEDiscontinued
DOBUTAMINE HYDROCHLORIDE EQ 12.5MG BASE/ML · INJECTABLE · INJECTION

Approval history

2002-10-22Labeling · Supplement 7AP
1998-02-18Labeling · Supplement 3AP
1997-10-30Manufacturing (CMC) · Supplement 5AP
1997-09-22Manufacturing (CMC) · Supplement 4AP
1997-09-15Manufacturing (CMC) · Supplement 2AP
1996-12-10Labeling · Supplement 1AP
1995-02-21OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →